Adikali Kamara is a 36-year-old student nurse working in the government hospital in Kenema, a sprawling town on the fringe of the Sierra Leone’s Gola tropical rain forest.
Zambian Martha Nalishupe is torn between taking one more pill with her daily regimen of antiretrovirals, or run the risk of a miscarriage.
Thirteen-year-old Sampreeth Monteiro’s neighbours are suddenly taking his advice seriously. “Buy a Guppy fish, it will eat all the mosquito eggs in your house. You will not get malaria again.”
Enhanced efforts to fight malaria have saved an estimated 3.3 million lives and nearly halved the disease's global mortality rate since 2000, according to the latest edition of the World Health Organisation's (WHO) annual "World Malaria Report", released Wednesday.
In his 21 years Brian Gitta has had malaria too many times to count. And over the years, because of the numerous times he has had to have his blood drawn to test for the disease, he has developed a fear of needles. It is little wonder then that he and three of his fellow computer science students worked hard to develop a mobile phone app that detects malaria – without the use of needles.
A U.S.-based civil society coalition is calling on Congress and President Barack Obama’s administration to keep spending on global health aid at current levels, warning that recent budget cuts risk a dangerous backslide in health and development gains achieved over the past three decades.
A first-time ranking of 54 top research universities in the United States and Canada has found that a miniscule percentage of funding goes to neglected diseases, despite the outsized influence that public universities play in developing medicines for illnesses often ignored by the private sector.
As Thailand braces itself to combat drug-resistant malaria, a spread of small, nondescript buildings scattered close to corn and rice fields along its hilly, western border are being cast into a bigger, international role.
Innovation in the pharmaceutical industry has declined drastically in the last ten years despite the high profitability of the so-called "research-based" industry, and the availability of better and more powerful science and technological tools. Not only has productivity in terms of research fallen, but the vast majority of new molecules introduced to the market do not provide new therapeutic solutions since other treatments already exist, normally at a lower cost.
After weathering the departure of its executive director amidst a misallocation scandal earlier this year, the world's largest funder of programmes to address HIV/AIDS, tuberculosis and malaria is poised to announce a new leader Thursday.
Researchers unveiling critical trial results of a potentially major anti-malaria vaccine are expressing disappointment that the drug’s efficacy levels have proved lower than they had anticipated.
In Papua New Guinea, a Pacific Island nation located south of the equator, 90 percent of the population is at risk of malaria and 1.9 million cases are reported every year. But, according to a recent medical study, a programme to distribute long-lasting insecticide treated mosquito nets to every district in the country has dramatically reduced malaria infections.